Allgens Medical Technology CO., LTD. (SHA:688613)
20.61
+0.99 (5.05%)
Sep 29, 2026, 2:15 PM CST
SHA:688613 Market Cap
SHA:688613 has a market cap or net worth of 2.69 billion as of September 28, 2026. Its market cap has decreased by -22.76% in one year.
Market Cap
2.69B
Enterprise Value
1.72B
Revenue
227.76M
Ranking
n/a
PE Ratio
311.90
Stock Price
20.61
ChartMarket Cap Chart
Since May 21, 2021, SHA:688613's market cap has decreased from 12.67B to 2.69B, a decrease of -78.78%. That is a compound annual growth rate of -25.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 2.69B | -3.40% |
| Dec 31, 2025 | 2.78B | 13.79% |
| Dec 31, 2024 | 2.45B | -17.61% |
| Dec 29, 2023 | 2.97B | -4.95% |
| Dec 30, 2022 | 3.12B | -57.62% |
| Dec 31, 2021 | 7.37B | -41.84% |
| May 21, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Succeeder Technology | 3.31B |
| Tellgen | 3.29B |
| Chison Medical Technologies | 3.25B |
| Shanghai ZJ Bio-Tech | 3.25B |
| Beijing Leadman Biochemistry | 3.23B |
| Wuhan Easy Diagnosis Biomedicine | 3.21B |
| Shanghai Kehua Bio-Engineering Co.,Ltd | 3.06B |
| Jiangsu Canopus Wisdom Medical Technology | 2.91B |